Clinical Trial Update: Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study of Sumatriptan Succinate tablets 100 mg under fed conditions in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan succinate tablets 100 mg (sumatriptan)

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Healthy | Phase 1 | Status: COMPLETED